Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript
|
ARYx Therapeutics, Inc. (ARYX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/14/2011 |
4
| Growth Equity Opportunities Fund, LLC (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
03/14/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/14/2011 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Sold 4,469,274 shares
@ $0.073, valued at
$326.3k
|
|
03/14/2011 |
4
| KOLLURI KRISHNA KITTU (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Sold 4,469,274 shares
@ $0.073, valued at
$326.3k
|
|
03/14/2011 |
4
| KERINS PATRICK J (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Sold 4,469,274 shares
@ $0.073, valued at
$326.3k
|
|
10/04/2010 |
4
| SIMON NICHOLAS J III (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
10/04/2010 |
4
| MPM BIOVENTURES III-QP L.P. (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
10/04/2010 |
4
| EVNIN LUKE (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Bought 500,000 warrants
@ $0.5, valued at
$250k
|
|
08/17/2010 |
4
| EVNIN LUKE (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
08/17/2010 |
4
| MPM BIOVENTURES III-QP L.P. (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
08/17/2010 |
4
| SIMON NICHOLAS J III (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/03/2010 |
4
| Ekman Lars (Director) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Granted 6,666 options to buy
@ $0.88, valued at
$5.9k
|
|
05/03/2010 |
4
| Leonard Keith R (Director) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/03/2010 |
4
| ROSENMAN HERM (Director) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Granted 6,666 options to buy
@ $0.88, valued at
$5.9k
|
|
05/03/2010 |
4
| SIMON NICHOLAS J III (Director) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Granted 6,666 options to buy
@ $0.88, valued at
$5.9k
|
|
05/03/2010 |
4
| SEKHRI PAUL J (Director) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/03/2010 |
4
| BEIER DAVID W (Director) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Granted 6,666 options to buy
@ $0.88, valued at
$5.9k
|
|
03/19/2010 |
4
| Barker Jason (Sr.Dir.& Principal Acctg. Off.) has filed a Form 4 on ARYx Therapeutics, Inc. |
03/02/2010 |
4
| Nagler David (V.P.,Corp. Affairs & Sect.) has filed a Form 4 on ARYx Therapeutics, Inc. |
03/01/2010 |
4
| Druzgala Pascal (Sr. V.P. & Chief Scien.Off.) has filed a Form 4 on ARYx Therapeutics, Inc. |
03/01/2010 |
4
| Varian John (COO & CFO) has filed a Form 4 on ARYx Therapeutics, Inc. |
03/01/2010 |
4
| Milner Peter G (Pres., Research & Dev.) has filed a Form 4 on ARYx Therapeutics, Inc. |
03/01/2010 |
4
| GODDARD PAUL (Chairman & CEO) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns:
| Granted 250,000 restricted stock units
@ $0 |
|
08/19/2009 |
4
| Druzgala Pascal (Sr. V.P. & Chief Scien.Off.) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/26/2009 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/01/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
05/01/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
05/01/2009 |
4
| Leonard Keith R (Director) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/01/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
05/01/2009 |
4
| SEKHRI PAUL J (Director) has filed a Form 4 on ARYx Therapeutics, Inc. |
05/01/2009 |
4
| BEIER DAVID W (Director) has filed a Form 4 on ARYx Therapeutics, Inc. |
02/20/2009 |
4
| Barker Jason (Sr.Dir.& Principal Acctg. Off.) has filed a Form 4 on ARYx Therapeutics, Inc. |
02/20/2009 |
4
| Canafax Daniel (V.P. & CDO) has filed a Form 4 on ARYx Therapeutics, Inc. |
02/20/2009 |
4
| Nagler David (V.P.,Corp. Affairs & Sect.) has filed a Form 4 on ARYx Therapeutics, Inc. |
|
|
|